全文获取类型
收费全文 | 1793463篇 |
免费 | 132478篇 |
国内免费 | 2594篇 |
专业分类
耳鼻咽喉 | 23023篇 |
儿科学 | 59821篇 |
妇产科学 | 49563篇 |
基础医学 | 248681篇 |
口腔科学 | 48856篇 |
临床医学 | 154054篇 |
内科学 | 348314篇 |
皮肤病学 | 34943篇 |
神经病学 | 147448篇 |
特种医学 | 74076篇 |
外国民族医学 | 474篇 |
外科学 | 276354篇 |
综合类 | 42420篇 |
现状与发展 | 3篇 |
一般理论 | 546篇 |
预防医学 | 141447篇 |
眼科学 | 39377篇 |
药学 | 131657篇 |
3篇 | |
中国医学 | 3604篇 |
肿瘤学 | 103871篇 |
出版年
2018年 | 37186篇 |
2017年 | 29589篇 |
2016年 | 33735篇 |
2015年 | 16118篇 |
2014年 | 21656篇 |
2013年 | 32382篇 |
2012年 | 49693篇 |
2011年 | 66328篇 |
2010年 | 45240篇 |
2009年 | 37263篇 |
2008年 | 63925篇 |
2007年 | 69387篇 |
2006年 | 46824篇 |
2005年 | 47686篇 |
2004年 | 48510篇 |
2003年 | 48094篇 |
2002年 | 45090篇 |
2001年 | 76141篇 |
2000年 | 79049篇 |
1999年 | 66687篇 |
1998年 | 18054篇 |
1997年 | 16695篇 |
1996年 | 16525篇 |
1995年 | 16210篇 |
1994年 | 15284篇 |
1993年 | 14397篇 |
1992年 | 55567篇 |
1991年 | 53947篇 |
1990年 | 52747篇 |
1989年 | 50969篇 |
1988年 | 47343篇 |
1987年 | 46689篇 |
1986年 | 44396篇 |
1985年 | 42947篇 |
1984年 | 32114篇 |
1983年 | 27647篇 |
1982年 | 16248篇 |
1981年 | 14463篇 |
1979年 | 30572篇 |
1978年 | 21132篇 |
1977年 | 17784篇 |
1976年 | 16768篇 |
1975年 | 17585篇 |
1974年 | 21526篇 |
1973年 | 20684篇 |
1972年 | 18860篇 |
1971年 | 17774篇 |
1970年 | 16325篇 |
1969年 | 15312篇 |
1968年 | 13977篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 下载免费PDF全文
53.
We report a case of intestinal obstruction in a 73-year-old woman caused by ileocolic intussusception. The underlying cause was a giant submucosal ulcerating lipoma (6?×?3.3?×?3.8 cm) extending from the superior mucosal lip of Bauhin’s valve. Abdominal ultrasonography showed a pathognomonic target-like mass appearing as multiple concentric rings. CT scan confirmed the diagnosis. Because of apparent obstruction, a laparotomy with right hemicolectomy and ileocolic anastomosis was performed. Lipomas most frequently occur in the cecum and ascending colon where they represent the most common submucosal mesenchymal tumor. They typically occur in elderly women with an incidence that varies from 0.15 to 0.56 %. Pain, rectal bleeding, and obstruction are typical symptoms. When faced with an intussusception in children, reduction with air per rectum can be performed. In adults, however, malignant cell spreading and seeding is of big concern. Since approximately 20–50 % of all underlying causes are malignant, explorative surgery is favored in adults. 相似文献
54.
55.
56.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
57.
58.
59.
R. E. J. Ryder 《Diabetic medicine》2015,32(3):305-313
On 8 April 2014, a US jury ordered Takeda and Eli Lilly to pay $9 bn in punitive damages after finding that they had concealed the cancer risks associated with pioglitazone. By contrast, on 28 August 2014, the long‐awaited outcome of the 10‐year Kaiser Permanente Northern California study was announced. That study was specifically designed to investigate whether patients exposed to pioglitazone were at an increased risk of bladder cancer and found no association; thus, at last, the controversial issue has been resolved. A review, in retrospect, of the story of the proposed link between pioglitazone and bladder cancer reveals flaws at every stage. In 2012, a BMJ editorial, in keeping with some other contemporary reports, stated ‘it can confidently be assumed that pioglitazone increases the risk of bladder cancer’. Examination of the information which led to such a statement shows that: 1) the pre‐clinical findings of bladder cancer in male rats is not indicative of human risk; 2) there is no association between bladder cancer and pioglitazone in randomized controlled trials, once cases that could not plausibly be related to treatment are removed; and 3) the observational studies that have suggested a link have over‐extrapolated from the data: pioglitazone‐treated patients had more risk factors for bladder cancer than those not treated with pioglitazone. Meanwhile careful study of randomized controlled trials shows evidence of cardiovascular benefit from pioglitazone in Type 2 diabetes, a condition which results, more than anything, in premature cardiovascular death and morbidity. 相似文献
60.